Filter
1644
Text search:
drug
registration
Featured
Recommendations
134
New Publications
532
Language
Document type
No document type
1058
Studies & Reports
218
Guidelines
174
Manuals
81
Strategic & Response Plan
66
Training Material
16
Fact sheets
13
Situation Updates
10
Resource Platforms
6
Brochures
1
Infographics
1
Countries / Regions
India
162
Kenya
58
Uganda
47
Ethiopia
42
Global
41
Tanzania
40
Sierra Leone
39
Nigeria
37
South Africa
37
Ghana
36
Bangladesh
35
Nepal
34
Malawi
34
Western and Central Europe
32
Liberia
30
Africa
30
Myanmar / Burma
29
Namibia
26
Rwanda
24
Zambia
21
Ukraine
21
Eastern Europe
19
Botswana
17
Latin America and the Carribbean
17
Zimbabwe
16
Cambodia
16
Lesotho
14
Philippines
13
Asia
12
South–East Asia Region
10
Syria
9
Indonesia
9
Congo, Democratic Republic of
8
Eswatini/ Swaziland
7
East and Southern Africa
6
West and Central Africa
6
Pakistan
5
Mozambique
5
Russia
5
Senegal
4
Benin
4
Colombia
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Albania
4
Tajikistan
4
Cameroon
3
South Sudan
3
Sudan
3
Sri Lanka
3
Venezuela
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Burkina Faso
2
Haiti
2
Iraq
2
Jordan
2
Afghanistan
2
Germany
2
Thailand
2
China
2
Papua New Guinea
2
Argentina
2
Brazil
2
North Macedonia
2
Bolivia
2
Libya
2
Chile
2
Western Pacific Region
2
Bhutan
2
Armenia
2
Laos
2
Iran
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Lebanon
1
Gambia
1
Malaysia
1
Ireland
1
Central African Republic
1
Peru
1
Greece
1
Angola
1
Madagascar
1
Paraguay
1
Fiji
1
Italy
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Vietnam
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
836
Clinical Guidelines
117
Public Health
75
Key Resources
44
Women & Child Health
42
Pharmacy & Technologies
34
Capacity Building
18
Toolboxes
TB
182
HIV
161
Mental Health
76
AMR
73
Pharmacy
70
NTDs
46
COVID-19
41
NCDs
30
Malaria
29
Caregiver
27
Conflict
25
Refugee
23
Global Health Education
17
Disability
16
Rapid Response
15
Ebola & Marburg
13
Health Financing Toolbox
8
Specific Hazards
7
Planetary Health
7
Natural Hazards
6
Polio
5
2.0 Rapid Response
4
Zika
2
Social Ethics
2
Cholera
1
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse
...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Revised Edition
World Drug Report 2018
-3-
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
...
Countries, partners, and donors are committed to the global elimination of blinding trachoma by 2020.
Achieving this public health milestone requires more than funding; it requires health personnel with the
right mix of skills, and well supported and managed health systems. Mass
...